Suchergebnisse - "Bajaj, Jasmohan S"

PubPharm (67)

11

Inadequate practices for hepatic encephalopathy management in the inpatient setting

enthalten in: Journal of hospital medicine | 2022

von Shaw, J. | Beyers, L. | Bajaj, J.

12

Promises of microbiome-based therapies

enthalten in: Journal of hepatology | 2022

von Bajaj, J. | Ng, S. | Schnabl, B.

13

Acute-on-Chronic Liver Failure Clinical Guidelines

enthalten in: The American journal of gastroenterology | 2022

von Bajaj, J. | O'Leary, J. | Lai, J. | +4

CommentIn: Hepatobiliary Surg Nutr. 2023 Apr 10;12(2):239-243. - PMID 37124683

14

Hepatic Encephalopathy and Liver Transplantation : The Past, Present, and Future Toward Equitable Access

enthalten in: Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society | 2021

von Acharya, C. | Bajaj, J.

15

The Use of Rifaximin in Patients With Cirrhosis

enthalten in: Hepatology (Baltimore, Md.) | 2021

von Caraceni, P. | Vargas, V. | Solà, E. | +44

16

The microbiota in cirrhosis and its role in hepatic decompensation

enthalten in: Journal of hepatology | 2021

von Trebicka, J. | Macnaughtan, J. | Schnabl, B. | +2

17

The Evolving Challenge of Infections in Cirrhosis

enthalten in: The New England journal of medicine | 2021

von Bajaj, J. | Kamath, P. | Reddy, K.

CommentIn: N Engl J Med. 2021 Sep 16;385(12):1150-1151. - PMID 34525295

18

Gut Microbiota Modulation and Fecal Transplantation : An Overview on Innovative Strategies for Hepatic Encephalopathy Treatment

enthalten in: Journal of clinical medicine | 2021

von Hassouneh, R. | Bajaj, J.

19

The Influence of the Microbiome on NAFLD and NASH

enthalten in: Clinical liver disease | 2021

von Albhaisi, S. | Bajaj, J.

20

Chronic Liver Diseases and the Microbiome-Translating Our Knowledge of Gut Microbiota to Management of Chronic Liver Disease

enthalten in: Gastroenterology | 2021

von Acharya, C. | Bajaj, J.